ADGM Adagio Medical Holdings, Inc. stock chart & analysis

Conviction 49Scan · Wed, Nov 4, 2026

Inverted hammer

Adagio Medical Holdings, Inc. (ADGM) closed at $0.0857 (-0.58%) on Nov 4, 2026. Its latest daily candle is a inverted hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 27, RS Rating 3, -94.9% from its 52-week high, -91.8% year to date. Sector: Surgical & Medical Instruments & Apparatus.

ADGM$0.0857-0.58%

ResistanceSupportVol 14

Loading chart…

Why ADGM moved

From the StockSetups movers recaps that covered ADGM, newest first. A recap states what was known that day.

Aug 4, 2026Close+76.1%
According to Quiver Quantitative, ADGM surged as investors reacted to a next-generation ULTA (Ultra-Low Temperature Ablation) milestone.
Top Stock Movers Today — August 4, 2026: Why ADGM, PLTU, PTIR, W & PLTR Surged →

Adagio Medical Holdings, Inc.Surgical & Medical Instruments & Apparatuswww.adagiomedical.com ↗

Price0.0857

Change-0.58%

Gap-0.70%

Rel volume0.23×

Avg volume2.17M

Avg $ vol228.6K

SMA 200.1054

SMA 500.2783

SMA 2000.7392

Price vs 50-69.21%

Price vs 200-88.41%

MA stackbearish

50/200 cross—

Supertrenddown · 0.1383

RSI (14)27

MACD hist0.01

MACD cross—

Stoch %K / %D11 / 12

ADX (14)51

+DI / −DI9 / 33

RSI divergenceBullish

MACD divergenceBullish

ATR %26.62%

ADR %14.68%

52w high1.69

52w low0.0810

From 52w high-94.93%

Above 52w low+5.80%

New 52w highNo

SqueezeOff

Bollinger width61.73%

%B0.20

Donchian pos7.73%

Donchian high0.1418

Donchian low0.0810

AVWAP (52w high)0.7029

vs AVWAP high-87.81%

AVWAP (52w low)0.0860

vs AVWAP low-0.39%

OBV trendUp

Chaikin MF (20)0.41

Today vs 20d0.23×

Avg vol (14d)773.03K

Avg vol (20d)2.17M

Avg $ vol (20d)228.6K

Market cap—

RS Rating3 / 99

RS 3m (vs SPY)-88.05%

RS 6m (vs SPY)-95.66%

RS line new highNo

Trend template0/8

Technical rank6.1

1 week-19.23%

1 month-37.90%

3 months-88.29%

6 months-91.17%

1 year-92.14%

YTD-91.76%

P/E-0.08

P/B-4.60

P/S—

P/FCF-0.10

EPS-1.51

Div yield—

ROE—

ROA-74.03%

Debt/Eq-59.85

Current1.41

EV/EBITDA-0.91

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth31.45%

Price target—

Target upside—

Analyst rating—

Institutional67.86%

Ent. value19M

Revenue0

Net income-6.72M

Gross profit—

Free cash flow-19.39M

IndustrySurgical & Medical Instruments & Apparatus

ExchangeNasdaq

Shares out22.21M

Employees41

ListedThu, Aug 1, 2024

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction49 / 100

Pattern quality—

Tech rank6.1 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmInverted hammer

Financials as of Tue, Jun 30, 2026 · quarterly.

ADGM technical analysis

Trend

ADGM is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 69.2% below the 50-day ($0.2783) and 88.4% below the 200-day ($0.7392). ADX(14) at 51 points to a strong, established trend. It meets 0 of 8 trend-template criteria.

Momentum

RSI(14) is 27, in oversold territory. The MACD histogram is positive. A bullish RSI divergence is in place. A bullish MACD divergence is in place. Its RS Rating of 3 puts its weighted 12-month performance ahead of about 3% of the US market.

Volume and volatility

Volume on the latest session ran 0.2× its 20-day average. It trades about $228,600 a day on average. ATR(14) is $0.0228, 26.6% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.41) shows accumulation.

Key levels

The 52-week range is $0.0810 to $1.69; price is 94.9% below the high and 5.8% above the low. The VWAP anchored at the 52-week high is $0.7029, above price.

Performance

ADGM returned -19.2% (1 week), -37.9% (1 month), -88.3% (3 months), -91.2% (6 months), -92.1% (1 year), -91.8% (year to date).

About Adagio Medical Holdings, Inc.

Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.

Surgical & Medical Instruments & Apparatus · Listed 2024 · 41 employees

Insider activity

SEC Form 4 transactions in ADGM

Insider	Side	Shares	Value	Traded	Filed
GARDINER SANDRA A. Director · Non-qualified stock option (right to buy) · 2026-06-16	Grant	30K	—	2026-06-16	2026-08-12
Cox James L Director · Non-qualified stock option (right to buy) · 2026-06-16	Grant	30K	—	2026-06-16	2026-08-12
Moran Timothy P. Director · Non-qualified stock option (right to buy) · 2026-06-16	Grant	30K	—	2026-06-16	2026-08-12
Salmon Sean Director · Non-qualified stock option (right to buy) · 2026-06-16	Grant	30K	—	2026-06-16	2026-08-12
MISHAN ORLY Director · Non-qualified stock option (right to buy) · 2026-06-16	Grant	100K	—	2026-06-16	2026-08-12
Mirsaeedi-Farahani Keyvan Director · Non-qualified stock option (right to buy) · 2026-06-16	Grant	30K	—	2026-06-16	2026-08-12

SEC filings

EDGAR filings in ADGM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.